National MS Society: Federal Trade Commission Releases New Report on Pharmacy Benefit Managers
January 18, 2025
January 18, 2025
NEW YORK, Jan. 18 (TNSres) -- The National Multiple Sclerosis Society issued the following news on Jan. 17, 2025:
Today, the U.S. Federal Trade Commission (FTC) published "Specialty Generic Drugs: A Growing Profit Center for Vertically Integrated Pharmacy Benefit Managers." This report focuses on pharmacy benefit managers' (PBMs) influence over specialty generic drugs, including significant price markups by PBMs on drugs used in the treatment of multiple sclerosis (MS . . .
Today, the U.S. Federal Trade Commission (FTC) published "Specialty Generic Drugs: A Growing Profit Center for Vertically Integrated Pharmacy Benefit Managers." This report focuses on pharmacy benefit managers' (PBMs) influence over specialty generic drugs, including significant price markups by PBMs on drugs used in the treatment of multiple sclerosis (MS . . .